Chronic inflammation is a well-known enabling characteristic of cancer, and IL-1 signaling, primarily through IL-1R1, is a primary regulator of the inflammatory response within the tumor microenvironment (TME), where its activation promotes a vicious cycle of tumor growth and spread (24). The gene discussed is IL1B; the disease is cancer.